CN Stock MarketDetailed Quotes

300239 Baotou Dongbao Bio-tech

Watchlist
  • 5.35
  • -0.02-0.37%
Market Closed May 17 15:00 CST
3.18BMarket Cap27.72P/E (TTM)

Baotou Dongbao Bio-tech Key Stats

All
YOY yoy
Hide blank lines yoy
(Q3)Mar 31, 2024
(FY)Dec 31, 2023
(Q9)Sep 30, 2023
(Q6)Jun 30, 2023
(Q3)Mar 31, 2023
(FY)Dec 31, 2022
(Q9)Sep 30, 2022
(Q6)Jun 30, 2022
(Q3)Mar 31, 2022
(FY)Dec 31, 2021
Total operating revenue
-7.48%241.78M
3.30%974.51M
4.05%734.67M
9.31%520.7M
14.53%261.32M
54.11%943.4M
71.26%706.04M
72.18%476.36M
65.13%228.17M
36.39%612.17M
Operating revenue
-7.48%241.78M
3.30%974.51M
4.05%734.67M
9.31%520.7M
14.53%261.32M
54.11%943.4M
71.26%706.04M
72.18%476.36M
65.13%228.17M
36.39%612.17M
Other operating revenue
----
-25.58%4.1M
----
15.42%1.93M
----
135.07%5.51M
----
28.03%1.67M
----
-6.27%2.34M
Total operating cost
-5.04%209.84M
1.79%834.26M
2.39%618.06M
8.09%439.44M
10.61%220.98M
41.19%819.58M
49.50%603.61M
48.16%406.56M
46.67%199.79M
33.28%580.48M
Operating cost
-1.55%191.38M
2.22%725.7M
2.68%538.07M
8.86%384.26M
12.23%194.4M
37.59%709.96M
45.32%524.01M
44.44%352.98M
43.06%173.21M
36.12%515.99M
Operating tax surcharges
-25.27%2.48M
0.44%12.58M
-0.47%9.65M
2.62%7M
5.03%3.32M
35.66%12.52M
56.98%9.69M
59.46%6.82M
44.75%3.16M
61.53%9.23M
Operating expense
-24.09%3.63M
9.95%19.61M
3.82%13.83M
9.65%9.32M
0.56%4.78M
72.42%17.84M
87.82%13.32M
94.58%8.5M
122.56%4.75M
12.81%10.35M
Administration expense
-18.96%10M
0.56%51.52M
-1.01%37.13M
2.21%25.89M
-1.54%12.34M
71.30%51.23M
80.76%37.51M
86.25%25.33M
89.50%12.54M
14.38%29.91M
Financial expense
-957.48%-1.7M
-157.07%-1.25M
-117.85%-360.13K
-99.25%14.44K
-79.22%198.3K
8.55%2.2M
-13.29%2.02M
-42.62%1.94M
-54.25%954.23K
-63.23%2.02M
-Interest expense (Financial expense)
-60.56%631.69K
-32.61%5.14M
-28.55%4.12M
-24.89%2.86M
8.29%1.6M
59.73%7.63M
33.65%5.77M
4.08%3.81M
-30.11%1.48M
-18.65%4.78M
-Interest Income (Financial expense)
-49.24%-2.18M
-31.54%-6.37M
-38.29%-4.41M
-73.60%-2.78M
-140.04%-1.46M
-68.20%-4.84M
-55.17%-3.19M
-379.69%-1.6M
-1,014.47%-608.71K
-451.50%-2.88M
Research and development
-32.00%4.05M
1.04%26.1M
15.73%19.74M
17.77%12.95M
14.85%5.95M
99.05%25.83M
149.80%17.06M
149.21%10.99M
143.07%5.18M
30.52%12.98M
Credit Impairment Loss
-64.66%62.02K
-200.06%-1.56M
-180.46%-510.79K
-90.89%44.13K
-48.34%175.5K
-147.19%-518.69K
-61.97%634.82K
-68.06%484.67K
-80.11%339.7K
253.71%1.1M
Asset Impairment Loss
-23.03%135.51K
-37.09%-1.45M
104.83%19.23K
358.82%177.31K
291.98%176.07K
-714.00%-1.06M
-459.31%-397.92K
-151.82%-68.51K
-201.69%-91.72K
136.47%172.1K
Adjustment items of total operating cost
----
----
----
----
----
----
---0.01
----
----
----
Other net revenue
85.51%1.63M
-45.93%3.62M
-54.04%2.33M
-67.10%844.87K
-6.13%877.46K
-33.04%6.7M
-40.46%5.06M
-64.66%2.57M
-76.47%934.78K
54.53%10.01M
Invest income
-51.86%-1.16M
-126.59%-4.33M
-407.39%-3.65M
-170.52%-2.39M
-27.79%-763K
24.39%-1.91M
57.09%-718.95K
24.20%-881.82K
-10.09%-597.07K
-80.79%-2.53M
-Including: Investment income associates
-51.86%-1.16M
-127.58%-3.84M
-609.73%-3.41M
-237.99%-2.35M
-48.50%-763K
12.14%-1.69M
60.91%-481.07K
13.40%-695.86K
-68.96%-513.82K
-129.33%-1.92M
Asset deal income
-18,340.61%-279.38K
-43.81%76.75K
54.99%28.5K
54.99%28.5K
-91.67%1.53K
46.49%136.58K
-80.28%18.39K
-78.10%18.39K
--18.39K
1,277.40%93.23K
Other revenue
122.81%2.87M
8.26%10.88M
16.50%6.44M
-1.15%2.98M
1.73%1.29M
-10.02%10.05M
-33.46%5.53M
-54.97%3.02M
-53.43%1.27M
39.13%11.17M
Operating profit
-18.55%33.57M
10.24%143.88M
10.64%118.93M
13.46%82.11M
40.58%41.21M
213.03%130.51M
531.87%107.49M
659.55%72.37M
394.26%29.32M
111.04%41.69M
Add:Non operating Income
231.95%33.14K
-4.05%1.62M
-23.00%495.06K
-91.28%36.96K
-74.82%9.98K
241.18%1.69M
2,376.26%642.9K
3,013.45%423.99K
854.75%39.64K
1,194.04%494.71K
Less:Non operating expense
681.72%875.74K
81.16%1.01M
66.53%425.24K
-39.81%227.94K
395.22%112.03K
-14.25%555.34K
878.45%255.36K
1,351.08%378.71K
--22.62K
397.15%647.6K
Total profit
-20.40%32.72M
9.76%144.49M
10.31%119M
13.13%81.92M
40.15%41.11M
216.91%131.65M
534.15%107.88M
661.02%72.41M
394.20%29.33M
111.25%41.54M
Less:Income tax cost
-27.72%4.64M
5.62%17.12M
10.56%17.07M
1.54%11.32M
38.82%6.42M
183.51%16.21M
362.14%15.44M
447.33%11.15M
246.56%4.63M
289.03%5.72M
Net profit
-19.04%28.08M
10.34%127.37M
10.27%101.93M
15.24%70.59M
40.40%34.69M
222.24%115.44M
576.19%92.44M
719.25%61.26M
437.05%24.71M
96.89%35.82M
Net profit from continuing operation
-19.04%28.08M
10.34%127.37M
10.27%101.93M
15.24%70.59M
40.40%34.69M
222.24%115.44M
576.19%92.44M
719.25%61.26M
437.05%24.71M
96.89%35.82M
Less:Minority Profit
-40.27%2.12M
24.79%7.49M
43.32%6.67M
70.15%5.59M
261.52%3.55M
1,006.91%6M
6,389.77%4.65M
4,538.66%3.28M
3,546.92%981.92K
-158.41%-661.44K
Net profit of parent company owners
-16.62%25.96M
9.55%119.89M
8.52%95.26M
12.12%65M
31.25%31.14M
199.96%109.44M
538.68%87.78M
667.73%57.97M
412.53%23.72M
97.74%36.48M
Earning per share
Basic earning per share
-16.76%0.0437
9.54%0.202
8.52%0.1605
12.08%0.1095
31.25%0.0525
185.01%0.1844
496.37%0.1479
588.03%0.0977
349.44%0.04
83.29%0.0647
Diluted earning per share
-23.81%0.04
6.24%0.1959
8.52%0.1605
12.08%0.1095
31.25%0.0525
185.01%0.1844
496.37%0.1479
588.03%0.0977
349.44%0.04
83.29%0.0647
Other composite income
Total composite income
-19.04%28.08M
10.34%127.37M
10.27%101.93M
15.24%70.59M
40.40%34.69M
222.24%115.44M
576.19%92.44M
719.25%61.26M
437.05%24.71M
96.89%35.82M
Total composite income of parent company owners
-16.62%25.96M
9.55%119.89M
8.52%95.26M
12.12%65M
31.25%31.14M
199.96%109.44M
538.68%87.78M
667.73%57.97M
412.53%23.72M
97.74%36.48M
Total composite income of minority owners
-40.27%2.12M
24.79%7.49M
43.32%6.67M
70.15%5.59M
261.52%3.55M
1,006.91%6M
6,389.77%4.65M
4,538.66%3.28M
3,546.92%981.92K
-158.41%-661.44K
Currency Unit
CNY
CNY
CNY
CNY
CNY
CNY
CNY
CNY
CNY
CNY
Accounting Standards
CAS (2007)
CAS (2007)
CAS (2007)
CAS (2007)
CAS (2007)
CAS (2007)
CAS (2007)
CAS (2007)
CAS (2007)
CAS (2007)
Audit Opinions
--
Unqualified opinion
--
--
--
Unqualified opinion
--
--
--
Unqualified opinion
Auditor
--
Shinnaganaka & Chung Certified Public Accountants (Special General Partnership)
--
--
--
Shinnaganaka & Chung Certified Public Accountants (Special General Partnership)
--
--
--
Shinnaganaka & Chung Certified Public Accountants (Special General Partnership)
(Q3)Mar 31, 2024(FY)Dec 31, 2023(Q9)Sep 30, 2023(Q6)Jun 30, 2023(Q3)Mar 31, 2023(FY)Dec 31, 2022(Q9)Sep 30, 2022(Q6)Jun 30, 2022(Q3)Mar 31, 2022(FY)Dec 31, 2021
Total operating revenue -7.48%241.78M3.30%974.51M4.05%734.67M9.31%520.7M14.53%261.32M54.11%943.4M71.26%706.04M72.18%476.36M65.13%228.17M36.39%612.17M
Operating revenue -7.48%241.78M3.30%974.51M4.05%734.67M9.31%520.7M14.53%261.32M54.11%943.4M71.26%706.04M72.18%476.36M65.13%228.17M36.39%612.17M
Other operating revenue -----25.58%4.1M----15.42%1.93M----135.07%5.51M----28.03%1.67M-----6.27%2.34M
Total operating cost -5.04%209.84M1.79%834.26M2.39%618.06M8.09%439.44M10.61%220.98M41.19%819.58M49.50%603.61M48.16%406.56M46.67%199.79M33.28%580.48M
Operating cost -1.55%191.38M2.22%725.7M2.68%538.07M8.86%384.26M12.23%194.4M37.59%709.96M45.32%524.01M44.44%352.98M43.06%173.21M36.12%515.99M
Operating tax surcharges -25.27%2.48M0.44%12.58M-0.47%9.65M2.62%7M5.03%3.32M35.66%12.52M56.98%9.69M59.46%6.82M44.75%3.16M61.53%9.23M
Operating expense -24.09%3.63M9.95%19.61M3.82%13.83M9.65%9.32M0.56%4.78M72.42%17.84M87.82%13.32M94.58%8.5M122.56%4.75M12.81%10.35M
Administration expense -18.96%10M0.56%51.52M-1.01%37.13M2.21%25.89M-1.54%12.34M71.30%51.23M80.76%37.51M86.25%25.33M89.50%12.54M14.38%29.91M
Financial expense -957.48%-1.7M-157.07%-1.25M-117.85%-360.13K-99.25%14.44K-79.22%198.3K8.55%2.2M-13.29%2.02M-42.62%1.94M-54.25%954.23K-63.23%2.02M
-Interest expense (Financial expense) -60.56%631.69K-32.61%5.14M-28.55%4.12M-24.89%2.86M8.29%1.6M59.73%7.63M33.65%5.77M4.08%3.81M-30.11%1.48M-18.65%4.78M
-Interest Income (Financial expense) -49.24%-2.18M-31.54%-6.37M-38.29%-4.41M-73.60%-2.78M-140.04%-1.46M-68.20%-4.84M-55.17%-3.19M-379.69%-1.6M-1,014.47%-608.71K-451.50%-2.88M
Research and development -32.00%4.05M1.04%26.1M15.73%19.74M17.77%12.95M14.85%5.95M99.05%25.83M149.80%17.06M149.21%10.99M143.07%5.18M30.52%12.98M
Credit Impairment Loss -64.66%62.02K-200.06%-1.56M-180.46%-510.79K-90.89%44.13K-48.34%175.5K-147.19%-518.69K-61.97%634.82K-68.06%484.67K-80.11%339.7K253.71%1.1M
Asset Impairment Loss -23.03%135.51K-37.09%-1.45M104.83%19.23K358.82%177.31K291.98%176.07K-714.00%-1.06M-459.31%-397.92K-151.82%-68.51K-201.69%-91.72K136.47%172.1K
Adjustment items of total operating cost ---------------------------0.01------------
Other net revenue 85.51%1.63M-45.93%3.62M-54.04%2.33M-67.10%844.87K-6.13%877.46K-33.04%6.7M-40.46%5.06M-64.66%2.57M-76.47%934.78K54.53%10.01M
Invest income -51.86%-1.16M-126.59%-4.33M-407.39%-3.65M-170.52%-2.39M-27.79%-763K24.39%-1.91M57.09%-718.95K24.20%-881.82K-10.09%-597.07K-80.79%-2.53M
-Including: Investment income associates -51.86%-1.16M-127.58%-3.84M-609.73%-3.41M-237.99%-2.35M-48.50%-763K12.14%-1.69M60.91%-481.07K13.40%-695.86K-68.96%-513.82K-129.33%-1.92M
Asset deal income -18,340.61%-279.38K-43.81%76.75K54.99%28.5K54.99%28.5K-91.67%1.53K46.49%136.58K-80.28%18.39K-78.10%18.39K--18.39K1,277.40%93.23K
Other revenue 122.81%2.87M8.26%10.88M16.50%6.44M-1.15%2.98M1.73%1.29M-10.02%10.05M-33.46%5.53M-54.97%3.02M-53.43%1.27M39.13%11.17M
Operating profit -18.55%33.57M10.24%143.88M10.64%118.93M13.46%82.11M40.58%41.21M213.03%130.51M531.87%107.49M659.55%72.37M394.26%29.32M111.04%41.69M
Add:Non operating Income 231.95%33.14K-4.05%1.62M-23.00%495.06K-91.28%36.96K-74.82%9.98K241.18%1.69M2,376.26%642.9K3,013.45%423.99K854.75%39.64K1,194.04%494.71K
Less:Non operating expense 681.72%875.74K81.16%1.01M66.53%425.24K-39.81%227.94K395.22%112.03K-14.25%555.34K878.45%255.36K1,351.08%378.71K--22.62K397.15%647.6K
Total profit -20.40%32.72M9.76%144.49M10.31%119M13.13%81.92M40.15%41.11M216.91%131.65M534.15%107.88M661.02%72.41M394.20%29.33M111.25%41.54M
Less:Income tax cost -27.72%4.64M5.62%17.12M10.56%17.07M1.54%11.32M38.82%6.42M183.51%16.21M362.14%15.44M447.33%11.15M246.56%4.63M289.03%5.72M
Net profit -19.04%28.08M10.34%127.37M10.27%101.93M15.24%70.59M40.40%34.69M222.24%115.44M576.19%92.44M719.25%61.26M437.05%24.71M96.89%35.82M
Net profit from continuing operation -19.04%28.08M10.34%127.37M10.27%101.93M15.24%70.59M40.40%34.69M222.24%115.44M576.19%92.44M719.25%61.26M437.05%24.71M96.89%35.82M
Less:Minority Profit -40.27%2.12M24.79%7.49M43.32%6.67M70.15%5.59M261.52%3.55M1,006.91%6M6,389.77%4.65M4,538.66%3.28M3,546.92%981.92K-158.41%-661.44K
Net profit of parent company owners -16.62%25.96M9.55%119.89M8.52%95.26M12.12%65M31.25%31.14M199.96%109.44M538.68%87.78M667.73%57.97M412.53%23.72M97.74%36.48M
Earning per share
Basic earning per share -16.76%0.04379.54%0.2028.52%0.160512.08%0.109531.25%0.0525185.01%0.1844496.37%0.1479588.03%0.0977349.44%0.0483.29%0.0647
Diluted earning per share -23.81%0.046.24%0.19598.52%0.160512.08%0.109531.25%0.0525185.01%0.1844496.37%0.1479588.03%0.0977349.44%0.0483.29%0.0647
Other composite income
Total composite income -19.04%28.08M10.34%127.37M10.27%101.93M15.24%70.59M40.40%34.69M222.24%115.44M576.19%92.44M719.25%61.26M437.05%24.71M96.89%35.82M
Total composite income of parent company owners -16.62%25.96M9.55%119.89M8.52%95.26M12.12%65M31.25%31.14M199.96%109.44M538.68%87.78M667.73%57.97M412.53%23.72M97.74%36.48M
Total composite income of minority owners -40.27%2.12M24.79%7.49M43.32%6.67M70.15%5.59M261.52%3.55M1,006.91%6M6,389.77%4.65M4,538.66%3.28M3,546.92%981.92K-158.41%-661.44K
Currency Unit CNYCNYCNYCNYCNYCNYCNYCNYCNYCNY
Accounting Standards CAS (2007)CAS (2007)CAS (2007)CAS (2007)CAS (2007)CAS (2007)CAS (2007)CAS (2007)CAS (2007)CAS (2007)
Audit Opinions --Unqualified opinion------Unqualified opinion------Unqualified opinion
Auditor --Shinnaganaka & Chung Certified Public Accountants (Special General Partnership)------Shinnaganaka & Chung Certified Public Accountants (Special General Partnership)------Shinnaganaka & Chung Certified Public Accountants (Special General Partnership)

FY: Financial Year. Refers to the 10-K file disclosed by the listed company to the SEC.

Q: Quarter. Refers to the 10-Q file disclosed by the listed company to the SEC. Q1, Q2, Q3, and Q4 are quarterly reports each with a span of 3 months; Q6 and Q9 are cumulative reports, with Q6 including 6 months and Q9 9 months.

Analysis

Analyst Rating

No Data

Price Target

No Data

Heat List
CN
Overall
Symbol
Latest Price
%Chg